Literature DB >> 20706192

Genetic variation of vascular endothelial growth factor pathway does not correlate with the severity of retinopathy of prematurity.

T Kusuda1, S Hikino, S Ohga, T Kinjo, M Ochiai, Y Takahata, S Tokunaga, K Ihara, Y Hata, T Hara.   

Abstract

OBJECTIVE: The aim of this study was to assess the genetic effects of the vascular endothelial growth factor (VEGF) pathway on retinopathy of prematurity (ROP). STUDY
DESIGN: A prospective study from a tertiary center that enrolled 204 Japanese infants (<35 weeks of gestational age (GA)) having no anomalies. ROP developed in 127, but not in 77 infants. The relative severity was defined as non-severe, moderate and severe ROP for GA, based on the staging criteria. VEGF (g.-634G>C, g.+13553C>T) and VEGF-receptor (KDR g.+4422(AC)11 to 14, Flt-1 c.+6724(TG)13 to 23) gene polymorphisms and clinical variables were assessed by uni/multivariate analyses. RESULT: The frequency of polymorphisms did not differ between ROP and non-ROP patients. The TT genotype of g.+13553 showed a higher odds ratio for non-severe ROP than CC genotype (P=0.006). Multivariate analyses indicated that low birth weight, blood transfusion and respiratory distress syndrome, but not polymorphisms, were the risk factors of advanced ROP (≥ stage 3).
CONCLUSION: A genotype of the VEGF pathway weakly affects the severity of ROP compared with other clinical factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20706192     DOI: 10.1038/jp.2010.111

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  6 in total

1.  Lack of association of VEGF gene 3'- UTR polymorphisms (C702T, C936T and G1612A) and the risk of developing advanced retinopathy of prematurity (ROP).

Authors:  Daniela Gismondi; Livja Ndoja; Xianggui Qu; Barkur S Shastry
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-07       Impact factor: 3.117

Review 2.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

Review 3.  Retinopathy of prematurity: contribution of inflammatory and genetic factors.

Authors:  Mariza Fevereiro-Martins; Hercília Guimarães; Carlos Marques-Neves; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2022-03-09       Impact factor: 3.396

4.  Association of VEGF gene polymorphisms with advanced retinopathy of prematurity: a meta-analysis.

Authors:  Peihui Liu; De Wu; Weiqin Zhou; Yawen Li; Chaohui Lian; Yueping Yang; Zhichun Feng
Journal:  Mol Biol Rep       Date:  2012-10-13       Impact factor: 2.316

5.  The genetics of retinopathy of prematurity: a model for neovascular retinal disease.

Authors:  Ryan Swan; Sang Jin Kim; J Peter Campbell; R V Paul Chan; Kemal Sonmez; Kent D Taylor; Xiaohui Li; Yii-Der Ida Chen; Jerome I Rotter; Charles Simmons; Michael F Chiang
Journal:  Ophthalmol Retina       Date:  2018-03-08

6.  Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia.

Authors:  Wojciech Podraza; Beata Michalczuk; Karolina Jezierska; Hanna Domek; Agnieszka Kordek; Beata Łoniewska; Monika Modrzejewska; Joanna Kot
Journal:  Open Med (Wars)       Date:  2018-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.